VGE III Portfolio Ltd.

10% owner at AXON ENTERPRISE, INC. · on record since Jul 13, 2016
10% owner at Arbutus Biopharma Corp · on record since Jul 13, 2016
10% owner at Myovant Sciences Ltd. · on record since Oct 26, 2016
10% owner at Wayfair Inc. · on record since Oct 8, 2014
10% owner at FIRST DATA CORP · on record since Oct 15, 2015
Former 10% Owner at Editas Medicine, Inc. · on record since Feb 9, 2016
10% owner at Editas Medicine, Inc. · on record since Feb 8, 2016
10% owner at Urovant Sciences Ltd. · on record since Sep 26, 2018
10% owner at Steel Excel Inc. · on record since Jun 26, 2019
Former 10% Owner at Arbutus Biopharma Corp · on record since Jul 12, 2019
Former 10% Owner at AXON ENTERPRISE, INC. · on record since Jul 12, 2019
Former 10% Owner at Urovant Sciences Ltd. · on record since Jul 12, 2019
Former 10% Owner at Myovant Sciences Ltd. · on record since Jul 12, 2019

Insider trading activity of VGE III Portfolio Ltd.

Transactions on record: 8; since Apr 4, 2018

Open-market buys: 8; $60.3M

Open-market sells: 0

Companies traded: 2; last filing Jun 19, 2019

Figures computed from official regulatory filings — .

Companies where VGE III Portfolio Ltd. has traded

Urovant Sciences Ltd.7 tx · $37.8M · Jun 19, 2019
Myovant Sciences Ltd.1 tx · $22.5M · Apr 4, 2018

Track record of VGE III Portfolio Ltd.

Open-market buys: 8

Last buy: Jun 19, 2019

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of VGE III Portfolio Ltd.

Co-insiders of VGE III Portfolio Ltd.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Urovant Sciences Ltd.Listing unverified	Jun 19, 2019	Buy	6,706	8.21 USD	$55.1K	conv 23Cluster	SEC
Urovant Sciences Ltd.Listing unverified	Jun 19, 2019	Buy	4,957	8.17 USD	$40.5K	conv 23Cluster	SEC
Urovant Sciences Ltd.Listing unverified	Jun 19, 2019	Buy	6,541	8.53 USD	$55.8K	conv 23Cluster	SEC
Urovant Sciences Ltd.Listing unverified	May 29, 2019	Buy	3,807	7.68 USD	$29.2K	conv 23Cluster	SEC
Urovant Sciences Ltd.Listing unverified	May 29, 2019	Buy	3,796	7.70 USD	$29.2K	conv 38Cluster	SEC
Urovant Sciences Ltd.Listing unverified	May 29, 2019	Buy	6,882	7.55 USD	$52K	conv 23Cluster	SEC
Urovant Sciences Ltd.Listing unverified	Oct 3, 2018	Buy	2,678,571	14.00 USD	$37.5M	conv 44Cluster	SEC
Myovant Sciences Ltd.Listing unverified	Apr 4, 2018	Buy	1,110,015	20.27 USD	$22.5M	conv 40ClusterFirst in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Urovant Sciences Ltd.Listing unverified	Jun 19, 2019	Buy	6,706	8.21 USD	$55.1K	conv 23Cluster	SEC
Urovant Sciences Ltd.Listing unverified	Jun 19, 2019	Buy	4,957	8.17 USD	$40.5K	conv 23Cluster	SEC
Urovant Sciences Ltd.Listing unverified	Jun 19, 2019	Buy	6,541	8.53 USD	$55.8K	conv 23Cluster	SEC
Urovant Sciences Ltd.Listing unverified	May 29, 2019	Buy	3,807	7.68 USD	$29.2K	conv 23Cluster	SEC
Urovant Sciences Ltd.Listing unverified	May 29, 2019	Buy	3,796	7.70 USD	$29.2K	conv 38Cluster	SEC
Urovant Sciences Ltd.Listing unverified	May 29, 2019	Buy	6,882	7.55 USD	$52K	conv 23Cluster	SEC
Urovant Sciences Ltd.Listing unverified	Oct 3, 2018	Buy	2,678,571	14.00 USD	$37.5M	conv 44Cluster	SEC
Myovant Sciences Ltd.Listing unverified	Apr 4, 2018	Buy	1,110,015	20.27 USD	$22.5M	conv 40ClusterFirst in 12mo	SEC